These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11098286)

  • 21. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
    Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shrinking genes for therapy.
    Bonetta L
    Nat Med; 2002 Mar; 8(3):222. PubMed ID: 11875490
    [No Abstract]   [Full Text] [Related]  

  • 23. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
    Albesa M; Ogrodnik J; Rougier JS; Abriel H
    Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.
    Schofield JN; Górecki DC; Blake DJ; Davies K; Edwards YH
    Dev Dyn; 1995 Oct; 204(2):178-85. PubMed ID: 8589441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gene therapy of monogenic hereditary diseases. Duchenne myodystrophy].
    Baranov VS; Baranov AN
    Vopr Med Khim; 2000; 46(3):279-92. PubMed ID: 11033887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
    Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
    FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
    Weir AP; Morgan JE; Davies KE
    Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
    Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
    Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.
    Ferrer A; Foster H; Wells KE; Dickson G; Wells DJ
    Gene Ther; 2004 Jun; 11(11):884-93. PubMed ID: 14985788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
    Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M
    J Neurosci Res; 1995 Nov; 42(4):528-38. PubMed ID: 8568939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.